E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 11/20/2018 in the Prospect News Distressed Debt Daily and Prospect News Emerging Markets Daily.

S&P trims YanAn Bicon

S&P said it lowered its issuer credit rating on YanAn Bicon Pharmaceutical Listed Co. (formerly Jiangsu Bicon Pharmaceutical Listed Co.) to CCC from B and placed the ratings on CreditWatch with developing implications.

“We lowered the issuer credit rating on YanAn Bicon due to company's significant near term maturities and insufficient cash on hand to repay the obligations,” S&P said in a news release.

These near-term maturities include RMB 1.8 billion of bonds with put options that will likely be exercised on Nov. 30 and Dec. 7 this year, the agency said.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.